Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6677)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamashita K, Ema A, Hosoda K, Mieno H, Moriya H, Katada N, Watanabe M. Macroscopic appearance of Type IV and giant Type III is a high risk for a poor prognosis in pathological stage II/III advanced gastric cancer with postoperative adjuvant chemotherapy. World J Gastrointest Oncol 2017; 9(4): 166-175 [PMID: 28451064 DOI: 10.4251/wjgo.v9.i4.166] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i4/166.htm |
| Number | Citing Articles |
| 1 |
Baohua Fan, Cunfang Shen, Milu Wu, Junhui Zhao, Qijing Guo, Yushuang Luo. miR-17–92 cluster is connected with disease progression and oxaliplatin/capecitabine chemotherapy efficacy in advanced gastric cancer patients. Medicine 2018; 97(35): e12007 doi: 10.1097/MD.0000000000012007
|
| 2 |
Kei Hosoda, Masahiko Watanabe, Keishi Yamashita. Re‐emerging role of macroscopic appearance in treatment strategy for gastric cancer. Annals of Gastroenterological Surgery 2019; 3(2): 122 doi: 10.1002/ags3.12218
|
| 3 |
Yingyi Zhang, Ting Han, Jie Li, Hui Cai, Jing Xu, Longpei Chen, Xianbao Zhan. Comprehensive analysis of the regulatory network of differentially expressed mRNAs, lncRNAs and circRNAs in gastric cancer. Biomedicine & Pharmacotherapy 2020; 122: 109686 doi: 10.1016/j.biopha.2019.109686
|
| 4 |
Yufei Wang, Tianyi Fang, Yimin Wang, Xin Yin, Lei Zhang, Xinghai Zhang, Daoxu Zhang, Yao Zhang, Xibo Wang, Hao Wang, Yingwei Xue. Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09594-1
|
| 5 |
Ji Hyun Kim, Han Hong Lee, Ho Seok Seo, Yoon Ju Jung, Cho Hyun Park. Borrmann Type 1 Cancer is Associated with a High Recurrence Rate in Locally Advanced Gastric Cancer. Annals of Surgical Oncology 2018; 25(7): 2044 doi: 10.1245/s10434-018-6509-3
|
| 6 |
Kei Hosoda, Chikatoshi Katada, Kenji Ishido, Masahiro Niihara, Hideki Ushiku, Mikiko Sakuraya, Marie Washio, Takuya Wada, Akinori Watanabe, Hiroki Harada, Takeo Sato, Hiroshi Tajima, Takashi Kaizu, Yoshimasa Kosaka, Hiroshi Kato, Norihiko Sengoku, Kiyoshi Tanaka, Takeshi Naito, Yusuke Kumamoto, Takafumi Sangai, Satoshi Tanabe, Wasaburo Koizumi, Keishi Yamashita, Naoki Hiki. Neoadjuvant chemotherapy plus surgery for high-risk advanced gastric cancer: long-term results of KDOG1001 trial. Langenbeck's Archives of Surgery 2020; 405(6): 777 doi: 10.1007/s00423-020-01924-w
|
| 7 |
Kei Hosoda, Mizutomo Azuma, Chikatoshi Katada, Hiromitsu Moriya, Hiroaki Mieno, Kenji Ishido, Akira Ema, Hideki Ushiku, Takuya Wada, Marie Washio, Akinori Watanabe, Katsuhiko Higuchi, Satoshi Tanabe, Wasaburo Koizumi, Masahiko Watanabe, Keishi Yamashita. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial. Gastric Cancer 2019; 22(3): 598 doi: 10.1007/s10120-018-0884-0
|
| 8 |
Hao Wang, Xin Yin, Keru Ma, Yufei Wang, Tianyi Fang, Yao Zhang, Yingwei Xue. Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer. Journal of Inflammation Research 2023; : 1059 doi: 10.2147/JIR.S404585
|